Dioscorea dumetorum-Fed Rats Exhibited Decreased Body Weight, Blood Glucose, and Insulin in STZ-induced Diabetes by Henrietta Aritetsoma Ogbunugafor et al.
Functional Foods in Health and Disease 2014; 4(2):87- 97                                                                  Page 87 of 97 
 Research Article                                                                                                           Open Access 
Dioscorea dumetorum-Fed Rats Exhibited Decreased Body Weight, Blood 
Glucose, and Insulin in STZ-induced Diabetes 
 
*Henrietta Aritetsoma Ogbunugafor
1,  Emmanuel Emeka Ilodigwe
2, 
 Daniel Lotanna 
Ajaghaku
2,
 Chinwe Nonyelum Ezekwesili
1, Chike Samuel Okafor
1, Chidinma Felicia 
Ajuzieogu
1,
 Shedrack Uche Madunatum
1   
 
1Department  of  Applied  Biochemistry,  Faculty  of  Biosciences,  Nnamdi  Azikiwe  University, 
P.M.B.5025,    Awka,  Nigeria; 
2Department  of  Pharmacology  and  Toxicology,  Faculty  of 
Pharmaceutical Sciences, Nnamdi Azikiwe University,  P.M.B.5025, Agulu, Nigeria. 
 
*Corresponding  author:  Henrietta  Aritetsoma  Ogbunugafor,  Department  of  Applied 
Biochemistry,  Nnamdi  Azikiwe  University,  Faculty  of  Biosciences,  Awka.  Anambra  State 
Nigeria 
 
Submission date: November 17, 2013; Acceptance date: February 17, 2014; Publication date:  
February 20, 2014  
 
ABSTRACT 
Background:  Preventive  measures  that  could  slow  down  the  rising  incidences  of  diabetes 
mellitus  are  essential.  The  use  of  neglected  local  foods,  which  have  effects  on  this  chronic 
disease beyond basic nutrition as dietary controls, is desirable. 
 
Objective: The effect of Dioscorea dumetorum (Kunth) Pax (Dioscoreaceae) feed on satiety, 
weight, blood glucose, and insulin levels were investigated in streptozotocin-induced diabetic 
rats. 
 
Methods: Twenty adult male rats in four groups of five were used for the experiment. Three 
groups – D. dumetorum, glibenclamide, and standard pellet-fed rats were induced with diabetes 
by i.p. administration of 50mg kg
-1 streptozotocin, while the fouth group (?) served as a non-
diabetic control. D. dumetorum was fed at 15g daily for ten days before induction, and after 
induction, feeding continued. Glibenclamide was orally administered 5mg kg
-1 daily. Both the 
untreated and non-diabetic rats were kept on standard rat pellets. Feed intake, weight, and blood 
glucose concentration were monitored daily, while insulin level was measured on day two and 
day six after inductions.   
 
Results: Average feed intake for non-diabetic rats was 15g for D. dumetorum per day, which 
dropped to 10.3g after induction of diabetes. Weight of normal non-diabetic rats consistently 
increased (142.61 ± 4.37g – 169.43 ± 8.61g) for the duration (17 days) of the experiment. The D. 
dumetorum-fed  rats  showed  weight  reduction  of  5.4%,  glibenclamide  4.0%,  and  untreated 
diabetic  6.15%.  Non-diabetic  rats  blood  glucose  levels  ranged  between  70  to  100mg  dL
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Streptozotocin (STZ) (i.p.) administration increased blood glucose levels from 370% to 626% in 
the  rats.  D.  dumetorum-fed  rats  showed  reduced  (p<0.05)  blood  glucose  levels  of  22.6%. 
Glibenclamide  had  5.5%  reduction  (p<0.05).  Insulin  was  absent  in  D.  dumetorum-fed  rats, 
whereas 0.95ng ml
-1 of insulin was detected in glibenclamide-administered rats. These quantities 
were lower (p<0.001) than 1.40ng ml
-1 in the non-diabetic rats.   
 
Conclusion:  This  study  revealed  that  D.  dumetorum  tuber  caused  decreased  hunger,  weight 
reduction, and displayed hypoglycemic property in diabetic rats, even after heat treatment. Its 
probable  mechanism  of  anti-hyperglycemic  activity  might  not  be  through  increased  insulin 
secretion. 
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Background: 
The  increased  prevalence  of  chronic  non-communicable  diseases,  such  as  type  2  diabetes, 
hypertension, and other cardiovascular diseases (CVD), [1] has made it essential to search for 
methods of control and management of these diseases in ways that are cheap, safe, and easily 
accessible. Diet control is becoming a major strategic approach to manage these diseases among 
caregivers, nutritionists, and researchers.  
The  basis  of  the  abnormalities  in  carbohydrate,  fat,  and  protein  metabolism  in  type  2 
diabetes is deficient action of insulin on target tissues. This results in inadequate insulin secretion 
and/or diminished tissue response to insulin at one or more points on the complex pathway of 
hormone action [2]. The global prevalence of the disease is estimated to increase from 4% in 
1995  to  5.4%  by  the  year  2025  [3].  One  of  the  reasons  adduced  for  this  rise  is  increased 
urbanization linked with lifestyle where daily routine requires less physical activity and greater 
access to foods with higher energy densities [4]. This has created a challenge of balancing both 
energy intake and expenditure leading to more people becoming overweight. Obesity and lack of 
physical activity have consistently been implicated in type 2 diabetes mellitus [5].  
Glycemic  control  is  a  key  to  management  of  the  disease.  Reports  state  that  intensive 
management of hyperglycemia in diabetes can significantly reduce complications, which suggest 
that most complications arising from the disease are not a part of the primary diabetic syndrome 
but  secondary  to  the  effect  of  chronic  hyperglycemia  [6].  Multiple  interventions  have  been 
developed over the years to achieve glycemic control. However, most of these interventions have 
not been successful due to numerous factors, such as undesirable side effects of hypoglycemic 
agents [3], cost, life style, and disregard of the occurrence of the disease. 
There is increasing awareness about the links between diet and diseases, such as certain fats 
and CVD, calcium and osteoporosis, and fiber and gastrointestinal health [4]. Therefore, the need 
to investigate indigenous foods that could act as functional foods has arisen from the relationship 
between diet, specific foods, and health. Currently, people’s interest in healthy living is moving 
towards  these  specific  foods.  Moreover,  scientific  evidence  lends  support  that  these  foods 
contain bioactive compounds that have positive effects on our health and well-being beyond 
simple nutritional requirement [4]. These types of foods that have positive effects on health 
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The concept of functional foods is predicated on considering that food is not only necessary 
for living but also as a source of mental and physical well-being and contributes to prevention 
and reduction of several risk factors of diseases [7]. They are not pills, capsules, or any other 
type of dietary supplements [4]. Currently, the trend in management of chronic diseases like 
diabetes is shifting from the use of synthetic agents to diet for glycemic control. This shift is to 
use foods from the local diet (What do you mean by this sentence?).  
Many  indigenous  foods  in  Nigeria  have  been  used  for  management  of  diabetes  in  the 
traditional healing system. Many of these foods have become neglected and are almost at the 
point of extinction. This work is an attempt to revert this trend by identifying and scientifically 
corroborating  the  potentials  of  these  foods  on  health  and  diseases.  One  of  these  foods  is 
Dioscorea dumetorum (Kunth) Pax (Dioscoreacea). D. dumetorum is a tuber with fleshy edible 
parts which can be yellow or white [8]. The tuber is commonly called cluster yam (because it 
occurs naturally in clusters), bitter yam or trifoliate yam, and it is called “ona” by the Igbos of 
Southeast Nigeria [9]. D. dumetorum is boiled and eaten as a snack in Southeast Nigeria. Its 
extract is used for the treatment of diabetes mellitus in traditional medicine [10]. The tubers are 
also  reported  to  be  rich  in  fiber  and  contain  an  alkaloid,  dioscorentine,  which  possesses 
hypoglycemic activity [11] [10]. 
Thus, the focus of the present study is to evaluate the potential of D. dumetorum to act as a 
functional food in the control of diabetes using STZ-induced diabetic rat model. Previous studies 
on D. dumetorum have concentrated on the evaluation of different solvent extracts of the tuber 
for its hypoglycemic property and not as food. Moreover, the effect of heat from cooking the 
bioactive component of the tuber, to the best of our knowledge, has also not been reported. The 
objective of this study is to assess the effect of feed from the boiled tubers on satiety, weight, 
blood glucose level, and serum insulin concentration in STZ-induced diabetic rats. 
 
MATERIALS AND METHODS: 
Chemicals: 
Hypoglycemic agent Glibenclamide (GlaxoSmithKline), D-glucose (Evans), Tween 80 (Sigma-
Aldrich,  Germany),  Streptozotocin  (Sigma-Aldrich,  Germany),  and  Eliza  immunoassay  kit 
ELX405
TM (Accubind, USA).  
 
Sample collection and authentication: 
The tubers of D. dumentorum were collected from a farm in Itu Ezinihitte Mbaise, Imo State. 
The  sample  was  identified  by  a  taxonomist,  Professor  Okeke  in  the  Department  of  Botany, 
Nnamdi Azikiwe University, Awka. 
 
Preparation of feed: 
The tubers (1000g) were properly washed, cooked, and the bark peeled and thinly sliced. The 
slices were air-dried at room temperature for two weeks on the laboratory bench. The dried slices 
were stored in an airtight container and refrigerated. 
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Animals:  
Wistar albino rats (20) were purchased from the animal house at the Faculty of Pharmaceutical 
Sciences, Nnamdi Azikiwe University, Agulu, Anambra State. The animals were kept in the 
animal laboratory with normal (twelve hour) daylight, housed in standard rat cages, and handled 
according to the guidelines for proper conduct of animal experimentation [12]. They were kept 
on commercial rat pellet and water ad libitum and acclimatized for seven days.   
 
Experimental design: 
All animals were weighed and sorted into four groups of five rats each. Sliced D. dumetorum 
feed was fed to the test (Group 1) rats for 10 days before induction of diabetes.  
 Group  1–  D.  dumetorum-fed  diabetic  rats,  Group  2–  Glibenclamide-administered  (oral) 
diabetic rats (Positive control), Group 3– Standard pellet-fed diabetic rats (Negative control), 
Group 4- Non-diabetic rats.  
 
Induction of experimental Type 2 Diabetes mellitus: 
The rats were fasted for 15 hours but were allowed access to water. The initial blood glucose 
levels  of the  rats  were  recorded (One Touch 2, Ultra  glucometer  Ifescan,  Inc.  USA) before 
induction of diabetes. Diabetes was induced intraperitoneally with streptozotocin 50mg kg
-1 body 
weight [13]. The animals were allowed food and water after the streptozotocin administration. 
Hypoglycemia in the rats was prevented by oral administration of 20ml 75% glucose solution 
one hour after induction. Blood glucose levels of the animals were determined 48 hours after 
induction.  When  the  blood  glucose  level  of  the  induced  rats  was  higher  than  200  mg  dL
-1, 
diabetes was confirmed. 
 
Animal feeding: 
The  diabetic  rats  in  the  test  group  received  15g  of  D.  dumetorum  feed  each  per  day.  The 
reference  drug  group  (positive  control)  was  orally  administered  5mg  kg
-1  body  weight  of 
glibenclamide (a standard hypoglycemic agent) dissolved in 10% between 80% (?) and were fed 
standard rat pellets. The untreated (negative control) did not receive any treatment and were fed 
standard rat pellets. The non-diabetic rats were fed standard rat pellets and served as the base line 
control rats.  
 
Determination of feed intake:  
This  study  was  carried  out  for  10  days.  The  test  group  rats  (D.  dumetorum)  were  housed 
individually and 5g of the feed was given to each rat. This quantity (g) was increased daily to 7, 
9, 11, 13, 15, 17, 19 and 21 depending on the leftovers of each animal. The leftovers were 
weighed every day and noted. The quantity of feed consumed daily by each rat was determined 
by deducting the weight of the leftovers from the initial weight of feed given daily. The average 
D. dumetorum feed consumed was then determined. After induction of diabetes and during the 
experiment, the average consumed feed was also determined. 
 
Death  rate,  weight  assessment  and  blood  glucose  concentration  determination:                 
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recorded.  The  weights  (g)  of  the  animals  were  determined  before  and  after  induction  of 
experimental diabetes and daily for the duration of the experiment. Blood glucose levels of the 
animals were monitored daily from tail blood using the ultra-glucometer.  
 
Insulin assay:  
Blood was collected by the retro-orbital plexus method from the rats two days after induction of 
diabetes and at the end of the experiment. Serum was collected and insulin concentration (ng) 
was determined by immunoassay using the Elisa ELX405
TM kit. 
 
Statistical analysis: 
Data collected after three measurements were analyzed with SPSS (version 17). Analysis was 
with one-way (ANOVA) for weight, blood glucose level and insulin concentration, and p<0.05 
was considered significant. 
 
RESULTS   
Feed consumption: 
The  normal  (non-diabetic)  rats  consumed  an  average  15g  of  D.  dumetorum  feed  per  day. 
However, after induction of diabetes, the D. dumetorum feed consumption dropped to 10.3g 
daily.  
 
Death rate: 
The summary of the animals’ death per day during the experiment is presented in Figure1. The 
D. dumetorum-fed rats had 60% survival rate by day six, glibenclamide had 20% while standard 
pellet-fed 0%.  
 
Table 1: DEATH RECORD OF DIABETIC RATS 
   Day  1    2  3  4  5  6  7 
D. dumetorum  ND  ND  1D  2D  ND  3D  NS 
Glibenclamide  ND  ND  2D  1D  1D  1D  NS 
Standard rat pellet  ND  2D  3D  NS  NS  NS  NS 
Non-diabetic  ND  ND  ND  ND  ND  ND  ND 
 
ND – No death; D – Death; NS – No survivor 
 
Weight Changes:  
The result of the weight assessment of the rats during the experiment is shown in figure 1. The 
weight of the normal non-diabetic rats consistently increased (142.61 ± 4.37g – 169.43 ± 8.61g)  Functional Foods in Health and Disease 2014; 4(2):87- 97                                                                  Page 92 of 97 
 
throughout the duration of the experiment. The D. dumetorum-fed rats showed weight reduction 
of  5.4%,  glibenclamide  exhibited  a  lower  percentage  in  weight  reduction  (4.0%)  and  the 
reduction was consistent throughout the experiment. The diabetic untreated (negative control)  
 
rats exhibited 6.15% reduction in weight, which was higher than both the D. dumetorum-fed and 
glibeclamide-administered rats. 
  
Blood glucose levels: 
Results presented in figure 2 show that normal rat blood glucose levels (70 – 100mg dL
-1) were 
observed in the control group of rats that were kept on the standard rat pellets throughout the 
duration of the experiment.  Intraperitoneal administration of streptozotocin (50mg kg
-1 body 
weight) to the animals produced appreciable increases (370% to 626%) in their blood glucose 
levels. D. dumetorum tuber feed reduced the blood glucose levels of the diabetic rats by 22.6% 
by the sixth day of feeding (i.e. from 492.22 ± 20.00 to 381.00 ± 17.00). This reduction in blood 
glucose  by  D.  dumetorum  feed  was  significant  (p<0.05)  when  compared  with  the  untreated 
diabetic  group.  All  the  untreated  diabetic  rats  died  before  the  end  of  the  experiment. 
Glibenclamide produced 5.5% reduction, which was lower (p<0.05) than the decrease caused by 
D. dumetorum.  
 
Insulin concentration: 
All the diabetic rats had higher levels of insulin than the non-diabetic group on day two after 
streptozotocin  administration  (Figure  3).  By  day  six,  insulin  was  completely  absent  in  the 
diabetic rats fed with D. dumetorum tuber feed, whereas 0.95ng ml
-1 of insulin was detected in Functional Foods in Health and Disease 2014; 4(2):87- 97                                                                  Page 93 of 97 
the group that received glibenclamide. These quantities were (p<0.001) lower than 1.40ng ml
-1 
observed in the non-diabetic rats. 
 
 
Fig. 2: Glucose concentration (mg dL
-1) in D. dumetorum-fed, glibenclamide-administered, 
standard rat pellet-fed and Non- diabetic rats  
 
 
 
 Functional Foods in Health and Disease 2014; 4(2):87- 97                                                                  Page 94 of 97 
DISCUSSION: 
From results of the present study, D. dumetorum exhibited important characteristics that point to 
its ability to act as an appropriate intervention tool. The tuber had positive effects on the amount 
of  feed  consumed,  body  weight,  blood  glucose  concentration,  and  insulin  concentration  of 
diabetic rats. The findings support that the tubers might be useful as a functional food in the 
animals used for this investigation. 
The reduction in D. dumetorum feed eaten by the diabetic rats observed in this experiment 
might be due to decreased hunger. D. dumetorum tuber has been reported to be composed of 
significant amount of fiber (3.47%), which is comparably higher than that of polished rice, water 
yam, and sweet potatoes [14]. Studies have it that the consumption of dietary fibers have a 
stomach  filling  effect,  which  might  have  resulted  in  reduced  feed  intake  by  the  rats  [15]. 
Consequently,  dietary  fiber  helps  in  weight  loss  and  decreases  the  risk  of  diabetes  and 
cardiovascular diseases [16]. Furthermore, the reduction in feed intake might be an indication 
that D. dumetorum feed suppresses appetite, thereby resulting in weight loss and the lowering of 
blood glucose levels. This is similar to the reduction in feed intake and body weight reported by 
Olubobokun et al., [17] following the treatment of diabetic rats with D. alata extract.   
Furthermore, it might also be possible that stimulation of the secretion, or action of the 
appetite–suppressing hormones (hypothalamic leptin, and intestinal mucosal cholecystokinin), as 
well as inhibition of the release of the appetite enhancing peptide–gherlin, may be part of the 
mode of action of the Dioscorea diet. This possibility is further strengthened by the point that 
some standard oral hypoglycemic agents, such as metformin, are well known for their appetite–
suppressant actions, and this property is responsible for their blood sugar lowering effects [18]. 
The death rate showed that more D. dumetorum-fed animals lived longer (60%) for the 
period  of  the  experiment  than  the  glibenclamide  (20%)  and  the  standard  pellet  (0%)  and  is 
indicative of a positive effect of the tuber on the physiological condition of the animals.    
The  weight  reduction  observed  in  D.  dumetorum-fed  diabetic  animals  finds  support  in 
epidemiological studies conducted on diabetic management and control interventions.  Franz [5] 
reported that intensive lifestyle intervention studies involving weight reduction of 5% decreased 
the overall risk of diabetes by 58% in human subjects. As stated earlier, obesity is a leading risk 
factor in development of diabetes. Currently, 1.1 billion people are overweight worldwide, a 
reason  that  has  contributed  to  the  increased  prevalence  of  type  2  diabetes  mellitus  [5].  In 
addition,  Eshghinia  and  Mohammadzadeh  [19]  found  that  weight  loss  programs  in  obese 
individuals produced lower incidences of type 2 diabetes mellitus and cardiovascular diseases. 
Moreover, the lowest percentage reduction in body weight recorded in the glibenclamide–treated 
diabetic rats is a confirmation that glibenclamide could encourage body weight gain. This is the 
most  frequently  reported  side  effect  associated  with  the  use  of  the  second-generation 
sulfonylureas in the management of Type 2 diabetes mellitus [20].  
The death of all untreated diabetic rats before the end of the experiment is as a result of a 
hyperglycemic coma, a major feature of type 2 diabetes mellitus.  The blood glucose lowering 
effect of D. dumetorum is validated by earlier reports on the hypoglycemic potentials of the 
tubers and bulbs of the Dioscorea family. Extracts of D. alata, D. bulbifera, D.hispida and D. 
domentorum reportedly reduced the blood glucose levels of the alloxan-induced diabetic rats [21-
24].  However,  the  study  revealed  that  D.  dumetorum  diet  was  significantly  (p<0.05)  more Functional Foods in Health and Disease 2014; 4(2):87- 97                                                                  Page 95 of 97 
efficacious in lowering animal’s blood glucose level than oral administration of the reference 
drug, glibenclamide (5mg/kg), which caused a 5.4% decrease. 
Several  modes  of  action  of  the  hypoglycemic  and  anti-hyperglycemic  medicinal  plants, 
herbs, and foods have been elucidated. Many of these plants inhibit endogenous glucose release 
[25] or impede the absorption of glucose from the gastrointestinal tract [26]. Pharmacologically 
active  ingredients  present  in  some  extracts  may  display  insulin-like  activity  [27],  inhibit 
insulinase activity, or enhance the secretion of insulin from the pancreatic β-cells of Islets of 
Langerhan [28, 29]. 
However, the elevated levels of insulin observed in all diabetic rats are more than the non-
diabetic rats and could be ascribed to the pancreatic hypertrophy, usually observed after the 
administration of streptozotocin and alloxan and prior to the development of hyperglycemia [30].  
Preliminary investigation into the mechanism of blood glucose lowering activity indicated a 
complete absence of insulin in the D. dumetorum-fed rats’ serum; in contrast, glibenclamide (a 
known  stimulator  of  insulin  secretion  by  pancreatic  β-cells)  suggests  that  increased  insulin 
secretion  may  not  be  the  mode  of  action  of  D.  dumetorum  tuber  feed.  However,  other 
mechanisms  such  as  inhibition  of  glucose  release  from  diet  or  inhibition  of  gastrointestinal 
glucose  absorption  would  be  investigated,  since  the  efficiency  of  D.  bulbifera  to  inhibit  α- 
amylase and α-glucosidase (key enzymes involved in the post-prandial release of glucose into the 
systemic circulation) activities have been documented [22]. 
 
CONCLUSION: 
In conclusion, this study confirmed the hypoglycemic property of D. dumetorum, even after heat 
treatment. This suggests that the tuber, which forms part of the population’s diet in the past, 
could be used for the management of diabetes mellitus. However, further work on the tuber 
would  be  carried  out  in  future  studies  to  establish  the  mechanism  of  the  action  of  its 
hypoglycemic activity.   
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